From Health Affairs Today <[email protected]>
Subject Stronger Evidence Standards Needed For Prescription Digital Therapeutics
Date November 28, 2023 9:02 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
📢 Join us for the Issue Briefing on 12/5 📢

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

Twitter ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

Tuesday, November 28, 2023 | The Latest Research, Commentary, and News from Health Affairs

Dear John,

Join us on December 5 for our issue briefing ([link removed] ) focusing on Global Lessons From COVID-19 at which authors from around the world will present their work, engage in discussions, and answer questions on these important issues.

Register below!

health-affairs-event-global-covid-19-lessons-05-12-23_eNewsletter-banner ([link removed] )

Evaluating Clinical Studies Of Prescription Digital Therapeutics

Digital therapeutics rely on software as the primary mechanism for diagnosis or intervention, and prescription digital therapeutics are a growing subset of digital therapeutics regulated by the Food and Drug Administration (FDA).

In the November issue of Health Affairs, Anika Kumar of the University of California San Francisco and coauthors analyze clinical studies of twenty prescription digital therapeutics authorized by the FDA and available on the market as of November 2022.

Kumar and coauthors identify a series of limitations in the rigor of evidence ([link removed] ) associated with these therapeutics, finding that “just 10 percent of these technologies were evaluated in at least one study that met all of the criteria for the highest strength of evidence,” and two-thirds of clinical studies examined were conducted on a postmarket basis with less rigorous standards of evidence than those standards used in premarket studies.

The researchers highlight the need for a more rigorous and inclusive approach to clinical research for prescription digital therapeutics.

Read the Article
([link removed] )

Arriving At A Fair Price In The Medicare Drug Price Negotiation Program: Considerations From Other Countries ([link removed] )

John K. Lin et al.

With today's featured article focusing on pharmaceuticals and medical technology, get the full story by exploring our extensive archive of podcasts on these topics.

Take a look below at a few highlighted episodes:

- A Health Podyssey: James Robinson on Life Sciences Innovation Acceleration ([link removed] ) (August 2023)
- Health Affairs This Week: The Long and Winding Road of Regulating Laboratory Developed Tests ([link removed] ) (August 2023)
- A Health Podyssey: Amelia Bond on 340B's Influence on Biosimilars ([link removed] ) (May 2023)

Celebrating National Family Caregivers Month

For the month of November, we are recognizing National Family Caregivers Month.

Throughout this month, we will be highlighting papers from over the years that illuminate this role through a health policy lens.

In the 2019 Community Care For High-Need Patients theme issue, Katherine Ornstein and coauthors consider the effects of caregiving in the last years of life ([link removed] ) on surviving spouses and how this can result in increased depression as well as negative health outcomes.

AD_42-12_Preorder_Issue_S10off_eNewsletter-banner ([link removed] )

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

Twitter ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

About Health Affairs

Health Affairs is the leading peer-reviewed journal ([link removed] ) at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online.

Sign up for all of our newsletters ([link removed] ) , including Health Affairs Today and Health Affairs Sunday Update.

Project HOPE ([link removed] ) is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Privacy Policy ([link removed] )

Health Affairs,1220 19th St. NW, Suite 800, Washington, DC, 20036, United States,

202-408-6801

Unsubscribe ([link removed] ) | Manage Preferences ([link removed] )
Screenshot of the email generated on import

Message Analysis